血管化复合组织移植用于烧伤重建的系统综述与荟萃分析
该系统综述与荟萃分析纳入2000年1月至2019年9月文献,评估血管化复合组织移植用于烧伤重建的安全性。
要点
- 烧伤重建VCA患者1年死亡率为12.0%,显著高于非烧伤患者的1.1%。
- 烧伤患者急性排斥发作次数为4.4次,高于非烧伤患者的2.4次。
- 烧伤VCA死亡病例中75%接受了三个或以上同期同种移植物。
核心结论
- 烧伤重建VCA与更高的1年死亡风险和近乎加倍的急性排斥发作相关。
研究设计与样本
- 共分析117例患者152次同种移植,其中面部移植45次、肢体移植107次。
主要发现
- 烧伤重建占34次移植(22%),涉及25例患者(21%)。
- 烧伤VCA死亡病例中75%接受了三个或以上同期同种移植物。
临床怎么用
- 对烧伤患者行VCA前应充分评估1年死亡风险和急性排斥风险。
- 同时植入多个同种移植物可能增加死亡风险,需谨慎决策。
局限性
- 本文为观察性荟萃分析,可能存在混杂偏倚。
- 纳入研究数量有限,部分文章缺乏已发表结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vascularized composite allotransplantation has been successfully employed for burn reconstruction since 2003. However, its safety in this population has been questioned due to high levels of alloimmunization from burn care-related tissue exposures. To investigate this, a systematic review of vascularized composite allotransplantation employed for burn reconstruction was conducted, evaluating literature from January 2000 to September 2019. Articles containing vascularized composite allotransplantation, composite tissue allotransplantation, and burn reconstructive surgery were included; articles without published outcomes were excluded. Observational meta-analysis of pooled mortality and acute rejection episodes relative to allograft type (face vs extremity) and reconstruction type (burn vs non-burn) was performed. Twenty-four of the 63 identified articles met the criteria for inclusion, with 5 more articles added after secondary review. To date, 152 allotransplantations have been performed in 117 patients: 45 face transplants and 107 extremity transplants. Of these, 34 (22%) were performed for burn reconstruction in 25 patients (21%) with an overall higher 1-year mortality rate (12.0% vs 1.1%, P = .030). Of these deaths, 75% received three or more simultaneous allografts. Additionally, more episodes of acute rejection occurred compared to non-burn patients (4.4 vs 2.4, P = .035). Vascularized composite allotransplantation performed for burn reconstruction was found to be associated with a greater risk of 1-year mortality and nearly twice the number of episodes of acute rejection. Future studies should seek to identify unique risk factors of burn patients undergoing this operation and evaluate the relationship between antigenic burden and surgical outcomes.
引用
- Gray KM, Peterson JM, Padilla PL, et al. Vascularized Composite Allotransplantation in Burn Reconstruction: Systematic Review and Meta-analysis. J Burn Care Res. 2021. PMID: 33091131. doi:10.1093/jbcr/iraa188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。